[68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy.

医学 核医学 标准摄取值 全身成像 四分位数 前列腺癌 Pet成像 置信区间 全身计数 正电子发射断层摄影术 内科学 癌症 放射性核素 物理 量子力学
作者
Phillip H. Kuo,Jacob Hesterman,Kambiz Rahbar,A. Tuba Kendi,Xiao X. Wei,Bruno Fang,Nabil Adra,Andrew J. Armstrong,Rohan Garje,Jeff M. Michalski,Samson Ghebremariam,Marcia Brackman,Connie Wong,Taylor L. Benson,Nicholas J. Vogelzang
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:40 (16_suppl): 5002-5002 被引量:56
标识
DOI:10.1200/jco.2022.40.16_suppl.5002
摘要

5002 Background: In the phase 3 VISION study, gallium ( 68 Ga) gozetotide ( 68 Ga-PSMA-11) PET/CT imaging was used to determine eligibility for lutetium ( 177 Lu) vipivotide tetraxetan ( 177 Lu-PSMA-617). Given that 177 Lu-PSMA-617 targets PSMA, we assessed the association between quantitative PSMA imaging parameters and treatment outcomes. Methods: In VISION, adults with mCRPC with ≥ 1 PSMA-positive (+) and no PSMA-negative lesions meeting the exclusion criteria were enrolled. In this sub-study, the association between imaging data from pre-enrollment 68 Ga-PSMA-11 PET/CT scans of pts in the 177 Lu-PSMA-617 group and clinical outcomes was assessed. Imaging data meeting quality requirements were analyzed for 548/551 pts. PSMA expression was quantified by 5 PET parameters: PSMA+ lesions by region, mean standardized uptake value (SUV mean ), maximum SUV (SUV max ), PSMA+ tumor volume, and tumor load (PSMA+ tumor volume × SUV mean ). Parameters were extracted from the whole body and 4 regions. Association between PET parameters and radiographic progression-free survival (rPFS; primary objective), overall survival (OS), objective response rate (ORR), and prostate–specific antigen 50 (PSA50) response was assessed. Results: Most pts (92.7%) had PSMA uptake in bone. In both the whole-body and regional analyses, statistically significant associations of PSMA PET parameters to clinical outcomes were observed (whole-body data shown in Table). Higher whole-body SUV mean was associated with improved clinical outcomes; pts in the highest quartile (SUV mean : rPFS, ≥ 10.2; OS, ≥ 9.9) had a median rPFS and OS of 14.1 and 21.4 months, vs 5.8 and 14.5 months for those in the lowest quartile (< 6.0; < 5.7), respectively. Absence of PSMA+ lesions in bone, liver, and lymph node, and lower PSMA+ tumor load, were indicators of good prognosis. Conclusions: Higher SUV mean is strongly associated with improved outcomes with 177 Lu-PSMA-617; clinical efficacy for different SUV levels vs the SoC arm is being assessed. Data support use of 68 Ga-PSMA-11 PET/CT scan to identify pts who will benefit from PSMA-targeted radioligand therapy.[Table: see text]
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
如意枫叶发布了新的文献求助10
1秒前
Rondab应助卡卡罗特采纳,获得10
4秒前
8秒前
12秒前
13秒前
芋孟齐发布了新的文献求助10
13秒前
17秒前
17秒前
一路生花完成签到,获得积分10
17秒前
orixero应助小慧儿采纳,获得10
17秒前
Ava应助科研通管家采纳,获得10
17秒前
17秒前
SYLH应助科研通管家采纳,获得10
17秒前
田様应助科研通管家采纳,获得10
18秒前
丘比特应助科研通管家采纳,获得10
18秒前
潇湘雪月发布了新的文献求助10
18秒前
今后应助科研通管家采纳,获得10
18秒前
科研通AI2S应助科研通管家采纳,获得10
18秒前
情怀应助科研通管家采纳,获得10
18秒前
打打应助科研通管家采纳,获得10
18秒前
18秒前
香蕉觅云应助科研通管家采纳,获得10
18秒前
18秒前
斯文败类应助科研通管家采纳,获得10
18秒前
wanci应助科研通管家采纳,获得10
18秒前
18秒前
爆米花应助科研通管家采纳,获得10
18秒前
SYLH应助科研通管家采纳,获得30
18秒前
星辰大海应助科研通管家采纳,获得10
18秒前
栗惠完成签到 ,获得积分20
18秒前
星辰大海应助科研通管家采纳,获得10
18秒前
李爱国应助科研通管家采纳,获得10
18秒前
猪猪hero发布了新的文献求助10
19秒前
科目三应助科研通管家采纳,获得10
19秒前
19秒前
19秒前
Bob完成签到,获得积分10
19秒前
22秒前
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989242
求助须知:如何正确求助?哪些是违规求助? 3531393
关于积分的说明 11253753
捐赠科研通 3270010
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136